by Five Rivers Rx | Jul 11, 2019 | Regulations
Photo courtesy of the Los Angeles Times Drug pricing has been a huge, very public issue over the past few years. Scandals have touched every part of the pharmacy world – brand drug companies have felt Congress’ wrath, compounding pharmacies are being taken down...
by Five Rivers Rx | Feb 12, 2019 | Industry News, VAWD
By now, OptumRx’s VAWD Accreditation requirement has become a ubiquitous part of the requirements for doing business in the pharmaceutical supply chain. In reading the policy, however, the requirements are not clear for manufacturers and those companies subject to...
by Five Rivers Rx | Jan 30, 2019 | Five Rivers, VAWD
We are excited to announce that our client, Teva Pharmaceuticals, was awarded VAWD® Reaccreditation at both of their distribution centers, in North Wales and New Britain (Chalfont), Pennsylvania! Over the past 11 months, Samuel Smith, Esq. led efforts in working with...
by Five Rivers Rx | Jan 3, 2019 | Industry News, NABP
Three generic drug wholesalers, Oak Drugs (“Oak”), Matrix Distributors (“Matrix”), and Primed Pharmaceuticals (“Primed”) are challenging Optum Rx’s VAWD Requirement. The plaintiffs have recently received encouraging news from the U.S District Court for the District of...
by Five Rivers Rx | Dec 11, 2018 | Industry News, Optum Rx, VAWD
After an eventful 27 months, OptumRx’s VAWD requirement will likely be fully enforced on vendors of OptumRx’s pharmacy network, starting January 1, 2019. OptumRx Extension Letters On December 10, 2018 OptumRx confirmed that the company will not be...
